Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 24;14(3):2678-2701.
doi: 10.1021/acsnano.0c00173. Epub 2020 Mar 3.

Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients

Review

Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients

Paul L Chariou et al. ACS Nano. .

Abstract

Nanocarrier-based delivery systems can be used to increase the safety and efficacy of active ingredients in medical, veterinary, or agricultural applications, particularly when such ingredients are unstable, sparingly soluble, or cause off-target effects. In this review, we highlight the diversity of nanocarrier materials and their key advantages compared to free active ingredients. We discuss current trends based on peer-reviewed research articles, patent applications, clinical trials, and the nanocarrier formulations already approved by regulatory bodies. Although most nanocarriers have been engineered to combat cancer, the number of formulations developed for other purposes is growing rapidly, especially those for the treatment of infectious diseases and parasites affecting humans, livestock, and companion animals. The regulation and prohibition of many pesticides have also fueled research to develop targeted pesticide delivery systems based on nanocarriers, which maximize efficacy while minimizing the environmental impact of agrochemicals.

Keywords: agrochemical delivery; cancer; clinical trials; drug delivery; gene delivery; nanocarrier; nanomedicine; pest management; precision farming; veterinary medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
Timeline and corresponding distribution of: (a) peer-reviewed publications involving nanoparticles in the medical, veterinary, and agricultural fields; (b) patent applications involving nanoparticles; (c) clinical trials using nanocarriers based on different materials; and (d) market approved nanocarrier formulations. See Methods section for more information on the data compilation and analysis.
Figure 2.
Figure 2.
Size and structure of nanocarriers (approved and in development). Adeno-associated virus (AAV, PDB ID: 1LP3), Herpes simplex virus (HSV, PDB ID: 5ZAP), Tobacco mild green mosaic virus TMGMV (PDB ID: 1VTM), ferritin (PDB: 6BP7), bacteriophage Qβ (PDB ID: 5KIP), and Cowpea mosaic virus (CPMV, PDB ID: 1NY7) were reconstructed using the UCSF Chimera software. The albumin, micelle, liposome, PLGA, chitosan polymer, mesoporous silica, and gold nanocarriers were rendered using Rhinoceros 3D v5.0. The carbon nanotube and dendrimer were drawn using ChemDraw software.

Similar articles

Cited by

References

    1. Eder J; Herrling PL Trends in Modern Drug Discovery. In New Approaches to Drug Discovery; Nielsch U, Fuhrmann U, Jaroch S, Eds.; Springer International Publishing: Cham, 2016; pp 3–22. - PubMed
    1. Hogan G; Tangney M The Who, What, and Why of Drug Discovery and Development. Trends Pharmacol. Sci 2018, 39, 848–852. - PubMed
    1. Holohan C; Van Schaeybroeck S; Longley DB; Johnston PG Cancer Drug Resistance: An Evolving Paradigm. Nat. Rev. Cancer 2013, 13, 714–726. - PubMed
    1. Mansoori B; Mohammadi A; Davudian S; Shirjang S; Baradaran B The Different Mechanisms of Cancer Drug Resistance: A Brief Review. Adv. Pharm. Bull 2017, 7, 339–348. - PMC - PubMed
    1. Maeda H; Tsukigawa K; Fang J A Retrospective 30 Years after Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy—Problems, Solutions, and Prospects. Micro-circulation 2016, 23, 173–182. - PubMed

Publication types